Original Research
Published on 08 Jul 2022
Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
in Gastrointestinal and Hepatic Pharmacology
- 10,368 views
- 53 citations










